AU Stock MarketDetailed Quotes

CBL Control Bionics Ltd

Watchlist
  • 0.052
  • +0.004+8.33%
20min DelayMarket Closed Jul 12 14:54 AET
10.36MMarket Cap-928P/E (Static)

Control Bionics Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Total revenue
24.08%5.44M
11.49%4.38M
3.93M
Operating revenue
24.08%5.44M
11.49%4.38M
--3.93M
Cost of revenue
-2.38%1.93M
38.32%1.98M
1.43M
Gross profit
45.87%3.5M
-3.86%2.4M
2.5M
Operating expense
8.67%9.79M
36.83%9.01M
6.58M
Selling and administrative expenses
5.06%5.91M
19.27%5.62M
--4.72M
-Selling and marketing expense
-13.37%616.56K
60.85%711.75K
--442.49K
-General and administrative expense
7.73%5.29M
14.96%4.91M
--4.27M
Research and development costs
-29.77%230.99K
97.84%328.88K
--166.23K
Depreciation amortization depletion
-5.40%480.45K
155.80%507.85K
--198.53K
-Depreciation and amortization
-5.40%480.45K
155.80%507.85K
--198.53K
Provision for doubtful accounts
643.77%629.33K
--84.61K
----
Other operating expenses
3.12%2.54M
63.82%2.46M
--1.5M
Operating profit
4.86%-6.29M
-61.72%-6.61M
-4.09M
Net non-operating interest income (expenses)
97.14%-1.19K
39.80%-41.67K
-69.22K
Non-operating interest income
1,417.78%20.14K
14.30%1.33K
--1.16K
Non-operating interest expense
38.52%12.31K
-72.89%8.89K
--32.78K
Total other finance cost
-73.55%9.02K
-9.28%34.11K
--37.6K
Other net income (expenses)
19.79%656.02K
-9.34%547.66K
604.07K
Other non-operating income (expenses)
19.79%656.02K
-9.34%547.66K
--604.07K
Income before tax
7.70%-5.63M
-71.83%-6.1M
-3.55M
Income tax
0
0
0
Earnings from equity interest net of tax
Net income
7.70%-5.63M
-71.83%-6.1M
-3.55M
Net income continuous operations
7.70%-5.63M
-71.83%-6.1M
---3.55M
Noncontrolling interests
Net income attributable to the company
7.70%-5.63M
-71.83%-6.1M
-3.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
7.70%-5.63M
-71.83%-6.1M
-3.55M
Diluted earnings per share
12.73%-0.0563
-26.32%-0.0645
-0.051
Basic earnings per share
12.73%-0.0563
-26.32%-0.0645
-0.051
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Total revenue 24.08%5.44M11.49%4.38M3.93M
Operating revenue 24.08%5.44M11.49%4.38M--3.93M
Cost of revenue -2.38%1.93M38.32%1.98M1.43M
Gross profit 45.87%3.5M-3.86%2.4M2.5M
Operating expense 8.67%9.79M36.83%9.01M6.58M
Selling and administrative expenses 5.06%5.91M19.27%5.62M--4.72M
-Selling and marketing expense -13.37%616.56K60.85%711.75K--442.49K
-General and administrative expense 7.73%5.29M14.96%4.91M--4.27M
Research and development costs -29.77%230.99K97.84%328.88K--166.23K
Depreciation amortization depletion -5.40%480.45K155.80%507.85K--198.53K
-Depreciation and amortization -5.40%480.45K155.80%507.85K--198.53K
Provision for doubtful accounts 643.77%629.33K--84.61K----
Other operating expenses 3.12%2.54M63.82%2.46M--1.5M
Operating profit 4.86%-6.29M-61.72%-6.61M-4.09M
Net non-operating interest income (expenses) 97.14%-1.19K39.80%-41.67K-69.22K
Non-operating interest income 1,417.78%20.14K14.30%1.33K--1.16K
Non-operating interest expense 38.52%12.31K-72.89%8.89K--32.78K
Total other finance cost -73.55%9.02K-9.28%34.11K--37.6K
Other net income (expenses) 19.79%656.02K-9.34%547.66K604.07K
Other non-operating income (expenses) 19.79%656.02K-9.34%547.66K--604.07K
Income before tax 7.70%-5.63M-71.83%-6.1M-3.55M
Income tax 000
Earnings from equity interest net of tax
Net income 7.70%-5.63M-71.83%-6.1M-3.55M
Net income continuous operations 7.70%-5.63M-71.83%-6.1M---3.55M
Noncontrolling interests
Net income attributable to the company 7.70%-5.63M-71.83%-6.1M-3.55M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 7.70%-5.63M-71.83%-6.1M-3.55M
Diluted earnings per share 12.73%-0.0563-26.32%-0.0645-0.051
Basic earnings per share 12.73%-0.0563-26.32%-0.0645-0.051
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg